MCTD: A concept which stood the test of time

Lupus

Volumn 11, Issue 6, 2002, Pages 333-339

  Sharp, G C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CORTICOSTEROID; NUCLEAR RNA; RIBONUCLEASE; RIBONUCLEOPROTEIN;

ANTIBODY TITER; COMPLEMENT FIXATION TEST; CONNECTIVE TISSUE DISEASE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; LUNG VASCULAR RESISTANCE; MIXED CONNECTIVE TISSUE DISEASE; OUTCOMES RESEARCH; POLYMYOSITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AUTOBIOGRAPHY; EVIDENCE-BASED MEDICINE; HISTORY, 20TH CENTURY; HUMANS; MIXED CONNECTIVE TISSUE DISEASE; PORTRAITS; UNITED STATES;

EID: 0036309840     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu220oa     Document Type: Review

References (29)

1. Mixed connective tissue disease - An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)
2. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases
3. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease
4. Cardiovascular manifestations of mixed connective tissue disease
5. Gastrointestinal manifestations of mixed connective tissue disease
6. Mixed connective tissue disease
7. Overlap syndromes: Mixed connective tissue disease and Sjögren's syndrome
8. The AI/RHEUM knowledge-based computer consultant system in rheumatology: Performance in the diagnosis of 59 connective tissue disease patients from Japan
9. Molecular relationships between two nuclear antigens, ribonucleoprotein and Sm: Purification of active antigens and their biochemical characterization
10. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus
11. The structure of mammalian small nuclear ribonucleoproteins: Identification of multiple protein components reactive with anti-(UI) ribonucleoprotein and anti-Sm autoantibodies
12. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus: A cross-sectional, longitudinal study
13. Intranuclear localization of snRNP antigens
14. Computer analysis of the distribution of nuclear antigens: Studies on the spatial and functional organization of the interphase nucleus
15. Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides
16. Antigenic domains on the U1 small nuclear ribonucleoprotein-associated 70K polypeptide: A comparison of regions selectively recognized by human and mouse autoantibodies and by monoclonal antibodies
17. Human autoantibodies against the 70 kD polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients
18. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70 kD autoantibody positive connective tissue disease patients
19. U1-70kD autoantibody-positive connective tissue disease in children: A longitudinal clinical and serologic analysis
20. Analysis of anti-U1 RNA antibodies in patients with connective tissue disease: Association with HLA and clinical manifestations of disease
21. Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct?
22. Mixed connective tissue disease: To be or not to be?
23. Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings
24. Analysis of human T cell and B cell responses against U-small nuclear ribonucleoprotein 70kD, B and D polypeptides among patients with systemic lupus erythematosus and mixed convective tissue disease
25. Structural analysis of TCR alpha and beta chains from human T-cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70kDa: TCR complementarity determining region 3 usage appears highly conserved
26. The appearance of U1-RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70kD and B′/B proteins as predominant U1-RNP immunogens
27. Autoantibody recognition of distinctly modified forms of the U1-70kD antigen is associated with different clinical disease manifestations